Anacardium Occidentale-Derived Nanoparticles as a Biocompatible Targeted Therapy for Breast Cancer Cells

Abstract

Breast cancer is a global health burden and therefore necessitates a continued exploration for new therapeutic mediators. In current scenario, nanotechnology has developed an interest in the application of nanoparticles in treating cancer. The need for new therapeutic agents against one of the global health burdens, breast cancer, is continuous. Nanoparticle application using nanotechnology for cancers has received increased interest in recent years. This review critically analyzes the bioactive compounds of Anacardium occidentale, commonly known as cashew, and their synthesized nanoparticles in relation to activities on cell lines responsible for breast cancer. These facts describe the phytochemical make-up of Anacardium occidentale's, approaches for nanoparticles synthesis, and their modes of action with respect to tumor cells; and implications for the elaboration of future approaches to the treatment of cancer.